Skip to main content
. 2019 Apr 5;74(Suppl 3):iii27–iii34. doi: 10.1093/jac/dkz088

Table 2.

Population PK model parameter estimates

Parametera Population mean
Magnitude of IIV
estimate SEM (%) estimate SEM (%)
Plasma
 CL (L/h) 159 5.61 16.1 57.7
Vc (L) 53.1 9.66 13.4 fixed
 CLD1 (L/h) 86.6 42.1 37.1 77.5
Vp1 (L) 656 27.4 24.7 fixed
 CLD2 (L/h) 199 16.1 23.5 69.1
Vp2 (L) 259 8.17 NE N/A
Ka (1/h) 1.20 11.6 108.2 38.5
Ka2 (1/h) 2.12 26.0 54.8 63.3
Ftot 0.24 7.99 22.8 84.6
 FS 0.80 8.35 55.7 74.2
 proportion of Ka when fed 0.04 14.7 NE NA
 proportion of Ka2 when fed 0.44 3.55 NE NA
 proportion of Ftot when fed 0.81 9.13 NE NA
ELF
Kin (1/h) 2.71 17.0 31.6 fixed
Kout (1/h) 0.51 27.5 31.6 fixed
Protein binding
Fumin 0.0997
Fumax 0.259
Cup50 (mg/L) 1.35
RV
 plasma proportional error 0.007 9.48 NE NA
 ELF proportional error 0.05 fixed NE NA

CL, total clearance of free drug; CLD1, distributional clearance to first peripheral compartment; CLD2, distributional clearance to second peripheral compartment; Cup50, concentration at which protein binding is half-maximal; Fumax, maximum extent of non-linear protein binding; Fumin, minimum extent of non-linear protein binding; NA, not applicable; NE, not evaluated; Vp1, volume of first peripheral compartment; Vp2, volume of second peripheral compartment.

a

Volumes and clearances are scaled to free-drug concentrations.